Dean Najarian - Concepedia

Author

Dean Najarian

Also Known As

D. Najarian, Dean M. Najarian, Dean Najarian

Publications

444

Citations

H-Index

Concepts

All Affiliations

Dean Najarian is an author at Janssen Scientific Affairs (United States) specializing in stigmatization, medicine, and psychiatry.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	51
2	Nursing	1	1	51
3	Public Health	1	1	51
4	Psychiatry	1	1	51
5	Mental Health	1	1	51

Dean Najarian

Publications

389

Citations

H-Index

Page 1

	Year	Citations
Olanzapine Increases Weight and Serum Triglyceride Levels David N. Osser, Dean Najarian, Robert L. Dufresne The Journal of Clinical Psychiatry	1999	231
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia Dean Najarian, Panna Sanga, Steven Wang, The International Journal of Neuropsychopharmacology	2021	57
Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs Vincent J. Giannetti, Charles F. Caley, Khalid M. Kamal, International Journal of Clinical Pharmacy NursingSocial StigmaMental Health ServicesStigmatizationCommunity Mental Health	2018	51
Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics Christoph U. Correll, Jennifer Kern Sliwa, Dean Najarian, CNS Spectrums	2018	23
Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia Dean Najarian, Ibrahim Turkoz, R Karl Knight, The International Journal of Neuropsychopharmacology	2023	14
An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate Jennifer Kern Sliwa, Adam Savitz, Isaac Nuamah, Perspectives In Psychiatric Care	2018	13

Page 1